Tilray Brands, Inc.

NASDAQ:TLRY

Drug Manufacturers - Specialty & Generic

Healthcare
$2.25 -0.84%

-$0.04 today

Market cap
$251.62M
Beta
1.88
P/E (TTM)
-0.3
EPS (TTM)
-$16.38
52W Low $3.50High $23.20

Volume 5.03M

Average 4.73M

TLRY Selling, General & Admin

Overhead costs of running the business, including sales, marketing, management, and administrative staff.

Tilray Brands, Inc.NASDAQ: TLRY

Selling, General & Admin · Q3 FY2026 · quarter ended Feb 2026

Selling, general & admin growth accelerates

Q3 FY2026 selling, general & admin of $95.08M rose 9.4% year over year, ahead of the -3.2% change in trailing-twelve-month selling, general & admin. Sequentially, it fell 6.9% from the prior quarter. Over 3 fiscal years it compounded at +15.1% a year.

Context

  • Selling, general & admin amounted to 31.6% of revenue in FY2025, down 0.2 pp from a year earlier.
  • Selling, general & admin increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether selling, general & admin reaches the consensus estimate from 7 analysts of $298M (-16.3%) for the fiscal year ending May 2026, a slowdown from the +4.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterFeb 2026
$95.08M-6.9% QoQ
Last fiscal yearMay 2025
$356.06M+4.2% YoY
LTMFeb 2026
$367.31M-3.2% YoY
Selling, General & Admin past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+9.4%-1.9%-11.4 pp
1 year+4.2%-16.3%-20.5 pp
3-year CAGR+15.1%+3.3%-11.8 pp
5-year CAGR+2.7%—
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Selling, General & Admin history

USD · from the income statement

Latest · FY2025
356.06M USD
Year-over-year change
+4.2%
4-year CAGR
+17.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Selling, General & Admin vs competitors

How TLRY compares with its peers on the latest reported figures

  • Peers report in different currencies, so selling, general & admin is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -3.2% is the 2nd highest of 3, against a peer median of -1.8%.
  • Selling, general & admin amounts to 31.1% of revenue for TLRY, versus a peer median of 38.1%.
TLRY Competitors
Selling, General & Admin for TLRY and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TLRYTilray Brands, Inc.LTM Feb 2026$367.31M USD-3.2%+15.1%31.1%
SNDLSNDL Inc.LTM Mar 2026CA$210.35M CAD-3.8%+10.0%22.4%
ACBAurora Cannabis Inc.LTM Mar 2026CA$166.84M CAD+0.2%+0.7%53.7%
GLASGlass House Brands Inc—— ———
Peer median (excluding TLRY) —-1.8%+5.3%38.1%

Competitors are the stored peer set for TLRY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
May 2021
FY2022
May 2022
FY2023
May 2023
FY2024
May 2024
FY2025
May 2025
Revenue619.67M792.12M844.72M1.07B1.13B
Cost of Revenue470.9M644.86M646.77M770.66M796.88M
Gross Profit148.77M147.26M197.95M304.33M330.11M
Gross Margin24.0%18.6%23.4%28.3%29.3%
Research & Development1M1.91M918.64K865.23K389.7K
Selling, General & Admin188.03M233.38M311.13M341.63M356.06M
Operating Expenses308.4M916.72M2.04B542.43M3.46B
Depreciation & Amortization81.92M194.88M175.31M172.93M183.17M
EBITDA(297.41M)(310.61M)(1.72B)(99.25M)(2.92B)
EBITDA Margin-48.0%-39.2%-203.1%-9.2%-259.0%
Operating Income(159.63M)(769.46M)(1.84B)(238.1M)(3.13B)
Operating Margin-25.8%-97.1%-218.4%-22.1%-277.9%
Interest Income3.53M14.79M44.48M17.48M15.61M
Interest Expense37.32M50.02M62.79M67.13M56.71M
Other Income / Expenses(257.02M)213.96M(108.43M)(101.2M)(26.99M)
Income Before Tax(416.65M)(555.51M)(1.95B)(339.31M)(3.16B)
Pre-Tax Margin-67.2%-70.1%-231.2%-31.6%-280.3%
Income Tax Expense(10.84M)(8.25M)(9.67M)(36.27M)(166.06M)
Net Income(443.75M)(601.05M)(1.96B)(333.8M)(3B)
Net Margin-71.6%-75.9%-231.6%-31.1%-266.3%
EPS (Basic)(13.61)(9.94)(31.70)(4.50)(33.80)
EPS (Diluted)(13.61)(9.94)(31.70)(4.50)(33.80)
Weighted Avg Shares26.95M48.12M61.8M74.26M89.03M
Weighted Avg Shares (Diluted)26.95M48.12M61.8M74.26M89.03M

Tilray Brands, Inc.

NASDAQ:TLRY

Intrinsic Alpha fair value

Locked

Current Price

$2.25

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.